Chiesi Italia
Clinical trials sponsored by Chiesi Italia, explained in plain language.
-
Asthma inhaler switch may help patients breathe easier, study finds
Disease control CompletedThis study looked at 620 adults with asthma that was not well controlled on their current treatment. They were given a combination inhaler (beclometasone/formoterol) to use daily. After 6 months, researchers measured how many patients improved their asthma control using a standar…
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a single triple inhaler tame asthma in the real world?
Disease control CompletedThis study follows adults with asthma whose doctors have prescribed a single-inhaler triple therapy combining an anti-inflammatory steroid, a long-acting bronchodilator, and an anticholinergic. Researchers will collect data from routine care visits to see how well the treatment c…
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New study tracks COPD patients on trimbow: better breathing or just better compliance?
Symptom relief CompletedThis study followed 661 Italian adults with moderate to severe COPD who were prescribed the Trimbow inhaler. Researchers measured changes in health status using the COPD Assessment Test (CAT) and how well patients stuck to their medication over 12 months. The goal was to see if t…
Sponsor: Chiesi Italia • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC